We are live on ! Find out more
B

Bailard Portfolio holdings

AUM $4.35B
1-Year Est. Return 23.57%
This Fund
S&P 500
This Quarter Est. Return
-4.61%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$2.42B
AUM Growth
-$122M
Cap. Flow
+$14.9M
Cap. Flow %
0.62%
Top 10 Hldgs %
32.13%
Holding
794
New
116
Increased
220
Reduced
211
Closed
134
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMRS
651
DELISTED
Amyris Inc.
AMRS
$48K ﹤0.01%
+16,600
New +$45.3K
LIAN
652
DELISTED
LianBio American Depositary Shares
LIAN
$39K ﹤0.01%
19,606
-27,991
-59% -$67K
BDTX icon
653
Black Diamond Therapeutics
BDTX
$105M
$36K ﹤0.01%
21,281
-37,219
-64% -$115K
CRVS icon
654
Corvus Pharmaceuticals
CRVS
$1.15B
$33K ﹤0.01%
+39,998
New +$38.2K
SAN icon
655
Banco Santander
SAN
$189B
$33K ﹤0.01%
14,362
+1,196
+9% +$2.99K
SPRB
656
Spruce Biosciences
SPRB
$124M
$29K ﹤0.01%
+282
New +$39.4K
DRCT icon
657
Direct Digital Holdings
DRCT
$1.94M
$23K ﹤0.01%
+47
New +$24.9K
OVID icon
658
Ovid Therapeutics
OVID
$448M
$22K ﹤0.01%
+11,800
New +$24.7K
ALGS icon
659
Aligos Therapeutics
ALGS
$29M
$21K ﹤0.01%
+776
New +$25.8K
UBX
660
DELISTED
Unity Biotechnology
UBX
$20K ﹤0.01%
+5,100
New +$32.2K
AAP icon
661
Advance Auto Parts
AAP
$3.22B
-1,601
Closed -$277K
ADEA icon
662
Adeia
ADEA
$2.97B
-119,826
Closed -$457K
ALK icon
663
Alaska Air
ALK
$4.99B
-7,879
Closed -$316K
ALKS icon
664
Alkermes
ALKS
$8.83B
-7,287
Closed -$217K
ALXO icon
665
ALX Oncology
ALXO
$272M
-15,510
Closed -$125K
AMRX icon
666
Amneal Pharmaceuticals
AMRX
$5.74B
-44,200
Closed -$141K
ANDE icon
667
Andersons Inc
ANDE
$2.66B
-17,600
Closed -$581K
APLE icon
668
Apple Hospitality REIT
APLE
$3.92B
-15,500
Closed -$227K
AQB icon
669
AquaBounty Technologies
AQB
$4.84M
-2,551
Closed -$87K
AUPH icon
670
Aurinia Pharmaceuticals
AUPH
$1.96B
-63,800
Closed -$641K
AVA icon
671
Avista
AVA
$3.49B
-5,368
Closed -$234K
AVD icon
672
American Vanguard Corp
AVD
$72.4M
-10,700
Closed -$239K
AVT icon
673
Avnet
AVT
$7.38B
-10,800
Closed -$463K
DCH
674
Dauch Corp
DCH
$1.33B
-50,900
Closed -$383K
BIP icon
675
Brookfield Infrastructure Partners
BIP
$18.9B
-6,216
Closed -$238K

Similar funds

Bailard's Q3 2022 Portfolio in Review

As of Q3 2022, Bailard held 794 positions worth $2.42B, down 4.8% from $2.54B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bailard's Q3 2022 filing shows 116 new, 220 increased, 211 reduced and 134 closed positions. Its largest new stake was iShares ESG Screened S&P Mid-Cap ETF: 141,107 shares worth $4.2M. The largest sale was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $69.2M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Bailard's largest Q3 2022 buy was iShares ESG Screened S&P Mid-Cap ETF: 141,107 shares worth $4.2M.
  • Bailard added most to iShares 1-3 Year Treasury Bond ETF in Q3 2022, an estimated $70.6M increase.
  • Bailard's biggest Q3 2022 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $69.2M.
  • Bailard fully exited First Trust Senior Loan Fund ETF in Q3 2022, selling an estimated $15.1M.
  • Bailard's ten largest holdings make up 32% of its $2.42B portfolio in Q3 2022.
  • Bailard opened 116 new positions and closed 134 in Q3 2022.
  • Bailard's portfolio value fell 4.8% quarter-over-quarter to $2.42B.

Based on Bailard's 13F filing for Q3 2022, filed 18 Oct 2022.